- Develop and lead CMC regulatory strategy for small molecule assets from IND/CTA through NDA filing and post-approval lifecycle management.
- Author, review, and oversee CMC sections of global submissions in ICH CTD format, including INDs, CTAs, NDAs, MAAs, variations, and supplements.
- Partner with Technical Development, Process Chemistry, Analytical Development, Formulation Sciences, and Quality on CMC regulatory matters.
- Lead FDA and EMA meetings and prepare responses to CMC deficiency letters and information requests from global regulatory agencies.
- Interpret FDA, EMA, and ICH CMC guidance and advise teams on design space, process validation, and control strategy acceptability.
- Lead post-approval CMC change management, including SUPAC assessments, PAS, CBE filings, and ex-US variations.
- Oversee regulatory aspects of technology transfer, CMO onboarding, site comparability, and related filing updates.
- Establish and maintain small molecule CMC regulatory SOPs, templates, and document management workflows.
- Assess CMC regulatory risks and readiness for small molecule licensing candidates and acquisition targets.
- Track regulatory deliverables, timelines, dependencies, risks, and milestones across small molecule programs.